neutral
4 days agoSudeep Pharma Debuts Strongly With Premium Listing Across NSE and BSE
Sudeep Pharma made a firm stock market debut today, listing at ₹730 on the NSE and ₹725 on the BSE, translating into a premium of more than 23% over its IPO price of ₹593. The ₹895-crore issue, which included anchor inflows of ₹268.5 crore, had attracted substantial demand with 93.71 times subscription.
Explore:Mutual Fund AI Screening
neutral
4 days agoSudeep Pharma Debuts Strongly With Premium Listing Across NSE and BSE
Sudeep Pharma made a firm stock market debut today, listing at ₹730 on the NSE and ₹725 on the BSE, translating into a premium of more than 23% over its IPO price of ₹593. The ₹895-crore issue, which included anchor inflows of ₹268.5 crore, had attracted substantial demand with 93.71 times subscription.
Explore:Mutual Fund AI Screening
1 min read
52 words
Sudeep Pharma listed over 23% above its IPO price after an issue subscribed 93.71 times, beating grey-market expectations and achieving an ₹8,188 crore valuation.
Sudeep Pharma made a firm stock market debut today, listing at ₹730 on the NSE and ₹725 on the BSE, translating into a premium of more than 23% over its IPO price of ₹593. The ₹895-crore issue, which included anchor inflows of ₹268.5 crore, had attracted substantial demand with 93.71 times subscription.
Sudeep Pharma made a firm stock market debut today, listing at ₹730 on the NSE and ₹725 on the BSE, translating into a premium of more than 23% over its IPO price of ₹593. The ₹895-crore issue, which included anchor inflows of ₹268.5 crore, had attracted substantial demand with 93.71 times subscription.
Nov 28, 2025 • 07:18